MIBG Uptake in a Gastric Gastrointestinal Stromal Tumor

Kun Zheng; Hongli Jing; Yimin Liu; Fang Li

doi:10.1097/RLU.0000000000004184

MIBG Uptake in a Gastric Gastrointestinal Stromal Tumor

Clin Nucl Med. 2022 Sep 1;47(9):e616-e617. doi: 10.1097/RLU.0000000000004184. Epub 2022 Mar 30.

Authors

Kun Zheng¹, Hongli Jing, Yimin Liu, Fang Li

Affiliation

¹ From the Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College; and Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China.

PMID: 35353762
DOI: 10.1097/RLU.0000000000004184

Abstract

MIBG scintigraphy is the imaging choice in the evaluation of pheochromocytoma and neuroblastoma. 131 I-MIBG uptake by gastrointestinal stromal tumors was rare. Here we report a case in which an increased 131 I-MIBG activity in an endoluminal gastric gastrointestinal stromal tumor was noted.

MeSH terms

3-Iodobenzylguanidine
Adrenal Gland Neoplasms* / diagnostic imaging
Gastrointestinal Stromal Tumors* / diagnostic imaging
Humans
Neuroblastoma* / diagnostic imaging
Pheochromocytoma* / diagnostic imaging
Radionuclide Imaging
Stomach Neoplasms* / diagnostic imaging

Substances

3-Iodobenzylguanidine